Rosutin 20 mg is a potent statin used for managing elevated cholesterol and reducing cardiovascular risk. It belongs to the class of other anti-anginal and anti-ischaemic drugs and works by selectively inhibiting HMG-CoA reductase, the key enzyme in cholesterol biosynthesis. By lowering LDL cholesterol and triglycerides while modestly increasing HDL cholesterol, Rosutin 20 mg helps prevent atherosclerosis and related cardiovascular events.

Rosutin 20 mg is indicated for heterozygous and homozygous hypercholesterolemia, mixed dyslipidemia (Fredrickson Type IIa and IIb), and as a primary prevention of cardiovascular disease in high-risk individuals. It not only reduces lipid levels but also improves overall lipid profile, supporting long-term cardiovascular health.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Rosutin 20 mg is recommended for:

• Heterozygous Hypercholesterolemia (Familial and Non-familial)

• Homozygous Hypercholesterolemia (Familial)

• Mixed Dyslipidemia (Fredrickson Type IIa and IIb)

• Primary prevention of cardiovascular disease in patients at high risk

Therapeutic Class

Other Anti-anginal & Anti-ischaemic drugs, Statins

Pharmacology

Rosutin 20 mg is a selective and competitive HMG-CoA reductase inhibitor. Its lipid-lowering effects occur via:

1. Increasing hepatic LDL receptor expression, enhancing LDL uptake and catabolism

2. Inhibiting hepatic VLDL synthesis, reducing VLDL and LDL particle formation

The combined action lowers total cholesterol, LDL, and triglycerides while modestly raising HDL, thus improving cardiovascular risk profile.

Dosage and Administration

Oral administration:

• Adults: 5–40 mg once daily; 40 mg reserved for patients not achieving LDL-C goals with 20 mg

• HoFH (Homozygous familial hypercholesterolemia): Starting dose 20 mg/day

• Pediatric patients with HeFH:

  • Ages 8–10 years: 5–10 mg/day

  • Ages 10–17 years: 5–20 mg/day

• Pediatric HoFH: 20 mg/day for ages 7–17 years

Rosutin 20 mg can be taken with or without food, at any time of day.

Drug Interactions

• Cyclosporine: Limit to 5 mg/day due to increased exposure

• Gemfibrozil: Avoid; if necessary, limit to 10 mg/day

• Lopinavir/Ritonavir or Atazanavir/Ritonavir: Limit to 10 mg/day

• Coumarin anticoagulants: May prolong INR; monitor closely

• Other lipid-lowering therapies (fibrates, niacin): Increased risk of muscle toxicity

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Contraindications

• Known hypersensitivity to Rosutin

• Active liver disease or persistent elevations in hepatic transaminases

• Pregnancy or women planning pregnancy

• Nursing mothers

Side Effects

Generally well tolerated. Common side effects include:

• Headache

• Myalgia (muscle pain)

• Constipation

• Asthenia (weakness)

• Abdominal pain

• Nausea

Precautions and Warnings

• Muscle-related effects: Myopathy and rhabdomyolysis risk increases with higher doses (40 mg), age >65, hypothyroidism, renal impairment, or concurrent use with certain drugs. Report unexplained muscle pain promptly.

• Liver monitoring: Check hepatic transaminases before and during therapy; discontinue if persistent elevation occurs.

• Pediatric use: Safety and effectiveness not established.

Pregnancy and Lactation

Safety in pregnancy has not been established. Rosutin 20 mg should not be used during pregnancy or lactation.

Storage Conditions

Store below 30°C, protected from light and moisture. Keep out of reach of children.

Mode of Action

Rosutin 20 mg competitively inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver, upregulating LDL receptors, and lowering circulating LDL and VLDL levels. This dual mechanism improves lipid profile and supports cardiovascular health.